Cardiac amyloidosis is a serious heart disease that is often diagnosed too late. During his PhD, Jiabin Qin developed human heart cell models, supporting earlier diagnosis and new treatments.
What innovative techniques can we use to treat rare metabolic disorders? Sabine and the team secured an ERC Proof of Concept grant to support this project.
New forms of dialysis, regenerative therapies, and even bioartificial kidneys are currently under development. But how do we ensure that these innovations will actually make their way to the patient?
In his inaugural speech, Mor Dickman shares how cell and gene therapy, AI, and value-based care are transforming ophthalmology and shaping the future of healthcare.
